Matches in Nanopublications for { <http://purl.org/np/RAvw8F2rV_yfYooruBvDAlNEOhbPf_t199nf4lj22XFXE#association> ?p ?o ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- association type Statement assertion.
- association label "zurampic is indicated in combination with a xanthine oxidase inhibitor for the treatment of hyperuricemia associated with gout in patients who have not achieved target serum uric acid levels with a xanthine oxidase inhibitor alone s ee clinical studies 14 zurampic is a urat1 inhibitor indicated in combination with a xanthine oxidase inhibitor for the treatment of hyperuricemia associated with gout in patients who have not achieved target serum uric acid levels with a xanthine oxidase inhibitor alone 1 limitations of use zurampic is not recommended for the treatment of asymptomatic hyperuricemia 1 1 zurampic should not be used as monotherapy 1 1 5 1 zurampic is not recommended for the treatment of asymptomatic hyperuricemia zurampic should not be used as monotherapy see warnings and precautions 5 1" assertion.
- association subject drugbank:DB11560 assertion.
- association predicate treats assertion.
- association object DOID_1920 assertion.
- association relation TreatmentIndication assertion.
- association association_type ChemicalToDiseaseOrPhenotypicFeatureAssociation assertion.
- association provided_by NeuroDKG assertion.